🔓
Sign in as a Member to unlock the full view of IONS. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
IONS

Ionis Pharmaceuticals, Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $13.47B

Ionis Pharmaceuticals is a biopharmaceutical company focused on RNA-targeted therapeutics, with its sole political signal being a disclosed dividend-generating stock holding by former President Donald J. Trump.

Next filing → your inbox
Govt Dependence
5/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat IONS does

Ionis Pharmaceuticals develops and commercializes RNA-targeted therapeutics, primarily for rare diseases. Its revenue is derived from collaborative R&D agreements, royalties, and product sales from partnered and wholly-owned drugs. The company's pipeline is heavily dependent on clinical trial outcomes and regulatory approvals from agencies like the FDA.

12 months past · 3 months futureIONS activity timeline

$89$58$26 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $86.50 hi $27.31 lo $29.06 CONGRESS 26 INSIDERS 3 13F FUNDS 30 BILLS 30 Hayden Michael R · · BUY 2026-07-30Hayden Michael R · · BUY 2026-07-31Hayden Michael R · · BUY 2026-11-10 Two Sigma Investments · + $496M · 2026-06-30Two Sigma Investments · + $440M · 2026-03-31Two Sigma Investments · - $210M · 2025-12-31Citadel Advisors · - $165M · 2025-12-31Citadel Advisors · + $135M · 2026-06-30Citadel Advisors · - $98M · 2026-03-31Citadel Advisors · + $88M · 2026-03-31Citadel Advisors · - $68M · 2026-06-30Two Sigma Investments · + $48M · 2025-12-31Renaissance Technologies · + $44M · 2026-06-30ARK Investment Management · + $41M · 2026-09-30D.E. Shaw & Co. · holds $35M · 2025-12-31D.E. Shaw & Co. · + $32M · 2026-03-31D.E. Shaw & Co. · - $30M · 2026-06-30 HR.2001 · passed_one · 2026-07-21 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
249 trading days · 0 congressional trades shown · 3 insider buys · 14 13F filings · 1 past bill actions · 5 upcoming markups

Executive Branch ConflictsIONS held by Trump-administration officials

1 cabinet/senior official reported IONS positions in OGE Form 278 disclosures across 1 filings.

Lifetime Government AwardsIONS federal contracts by year

$6M
total awarded · 2004–2005
2
contracts on file
2004
peak year ($6M)
$6M $3M 2004: $6M across 1 contract (peak year) $6M 2004 2005: $706K across 1 contract $706K 2005
Top contracts by award amount
$5.6M Department of Health and Human Serv 2004-09-30 ASSESSING THE SAFETY OF CELL SUBSTRATES AND VACCINE COMPONENTS
$706K Department of Defense 2005-04-14
2 years · 2 contracts

Smart Money · 13F HoldingsHedge funds holding IONS

$790.3M
Total IONS held by tracked 13F funds
8
Funds with IONS positions
Two Sigma Investments $496M +7% 2026-06-30
Citadel Advisors $135M +10010% 2026-06-30
Citadel Advisors $68M -99% 2026-06-30
ARK Investment Management $41M +207% 2026-09-30
D.E. Shaw & Co. $30M -10% 2026-06-30
Renaissance Technologies $16M -37% 2026-09-30
Point72 Asset Management $3M -8% 2026-06-30
AQR Capital Management $2M -23% 2026-06-30

Congressional TradesWho in Congress is trading IONS

2023-03-06 Daniel S. Goldman D-New York · house sale $1,001 - $15,000
2023-03-06 Daniel S. Goldman D-New York · house Sale $1,001 - $15,000
2023-03-14 Ro Khanna D-California · house sale $1,001 - $15,000
2023-03-14 Ro Khanna D-California · house Sale $1,001 - $15,000
2023-01-04 Ro Khanna D-California · house exchange $1,001 - $15,000
2023-01-04 Ro Khanna D-California · house Exchange $1,001 - $15,000
2019-05-08 Donna Shalala D-Florida · house purchase $1,001 - $15,000 355d late
2019-06-24 Donna Shalala D-Florida · house sale $1,001 - $15,000 308d late
2019-05-08 Donna Shalala D-Florida · house Purchase $1,001 - $15,000 355d late
2019-06-24 Donna Shalala D-Florida · house Sale $1,001 - $15,000 308d late
2019-04-29 Ro Khanna D-California · house sale $1,001 - $15,000
2019-04-29 Ro Khanna D-California · house Sale $1,001 - $15,000
26+ trades on file · most recent 2023-04-17

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Open-market buys

C
Insider signal score 50/100 · 1 distinct insiders · 3 open-market buys totaling $1.2M in the last 180 days.
2026-07-30 Hayden Michael R BUY 15,000 sh $801K

Stock awards & option exercises

9
option exercises · $3.5M
For IONS, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting IONSLive legislation impacting this stock

Political ProfileWhere IONS sits in Washington

[object Object]

STRUCTURAL: No lobbying spend (`get_political_influence.lobbying.total_income: 0`), no donations, and no federal contracts (`get_government_precedent.federal_contracts_summary: null`). EVIDENTIARY: One executive branch holding (`get_executive_branch_exposure.by_ticker[0].holdings[0].filer: Donald J. Trump`) with minimal reported value ('None (or less than $1,001)'), zero corporate insider buys in 180 days (`get_corporate_insider_signal.total_buys: 0`), and zero congressional traders. Net: Minimal direct political footprint.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • General legislative pressure on drug pricing and reimbursement
    Congress, HHS
    "Eight recent healthcare bills identified in `Recent bill_impacts` with non-zero impact_ratios."

Regulatory opportunities

  • Potential for favorable orphan drug or accelerated approval pathways
    FDA
    "Inferred from primary industry and sector, but no specific carveouts in `Recent bill_carveouts`."
Member intelligence layer

Live signals + predictions for IONS — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout IONS & political exposure

Does Ionis Pharmaceuticals, Inc. (IONS) hold federal contracts?
Yes. Ionis Pharmaceuticals, Inc. has 2 federal contract awards totaling $6,319,623, primarily from agencies including Department of Defense, Department of Health and Human Services. See full contract list and amounts on this page.
Which Trump cabinet officials own IONS stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in IONS on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded IONS stock?
26 congressional trades by 5 unique members of Congress, most recently on 2023-03-14. See the Congressional Trading panel for politician-by-politician breakdown.
What is IONS political risk profile?
Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track IONS political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. IONS data is updated daily from these official federal sources.